← All organizations

Institut d'Hématologie et d'Oncologie Pédiatrique, Lyon

Academic/Hospital

Also known as: IHOP | IHOP, Lyon

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 1, 2015

Timeline

No events for the selected filters.

Drugs by trial phase (9 distinct, 3 trials)

Phase 3 (7 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

lidocaine

Other trials (1 own, 0 via acquisition)

asparaginase

Indications

Studied for

Recent trials (3)

NCT02265770Overall official - principal investigatorPhase 2/Phase 3Apr 1, 2015
NCT02197650Overall official - principal investigatorN/AFeb 1, 2013
NCT01314300Overall official - principal investigatorPhase 2Mar 1, 2011

Details

Last known activity: Apr 1, 2015